European markets in mixed territory after a positive start
January 26, 2026
12 Sweet Feminine Aesthetic Outfits for the Summer Season
March 13, 2026
Bone marks suggest this hobbit was not a hunter
July 6, 2026
Anthropic deploys Claude Science, an AI workshop for pharmaceutical researchers. The bustling AI startup says this new product goes beyond ...
Read moreDetailsA Viridian Therapeutics drug for thyroid eye disease now has FDA approvalmaking it just the second treatment for this inflammatory ...
Read moreDetailsRegulatory pressure mounts on Amgen's inflammatory disorder drug Tavneos at the European Medicines Agency (EMA) recommend revocation of product approval ...
Read moreDetailsThe FDA has expanded approval of a targeted therapy from Gilead Sciences as a new first-line treatment for triple-negative breast ...
Read moreDetailsAfter a few gloomy years, biotech IPOs rebound in 2026. A new record for the sector most cash raised by ...
Read moreDetailsAbbVie strengthens its already strong presence in immunology with the acquisition of Apogée Therapeuticsa clinical-stage biotechnology whose most advanced drug ...
Read moreDetailsClinical AI startup Shorten is one of the best-funded health tech startups in the country, having raised $1.1 billion since ...
Read moreDetailsThe FDA's operational structure around centers, each governing a particular regulatory or scientific area, dates back more than 40 years. ...
Read moreDetailsServier is expanding its neurology focus to include neuromuscular disorders by acquiring a clinical-stage Edgewise Therapeutics drug that offers a ...
Read moreDetailsThis overview is published monthly. It aims to highlight some of the latest hiring news in the healthcare industry and ...
Read moreDetails© © Copyrights 2026 Vidianews. All Rights Reserved. Designed by Vidianews